← Eichor
Study identifier: NCT07131956 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

Condition: Prostate Cancer (Diagnosis) · Prostate Cancer Patients Who Have Brachytherapy Seed Implant · Prostate Cancer Patients Treated by Radiotherapy  ·  Sponsor: University of Erlangen-Nürnberg Medical School

PhaseN/A
Planned participants200
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Analysis of peripheral immune cells before, during, and after brachytherapy treatment. Corresponding analysis of tissue samples collected during brachytherapy treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Claudia Schweizer, MD  ·  +49 9131 85 33968  ·  claudia.schweizer@uk-erlangen.de

Anna-Jasmina Donaubauer, Dr. rer. nat.

Always discuss trial participation with your own doctor first.

Locations (3)

Klinik für StrahlentherapieAugsburg, Bavaria, GermanyNot Yet Recruiting
Strahlenklinik ErlangenErlangen, Bavaria, GermanyRecruiting
Klinik und Poliklinik für Strahlentherapie und RadioonkologieMunich, Bavaria, GermanyNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07131956